These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16686598)

  • 1. MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.
    Atkinson SJ; Roghi C; Murphy G
    Biochem J; 2006 Aug; 398(1):15-22. PubMed ID: 16686598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.
    Wang P; Nie J; Pei D
    J Biol Chem; 2004 Dec; 279(49):51148-55. PubMed ID: 15381707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
    EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
    Tam EM; Wu YI; Butler GS; Stack MS; Overall CM
    J Biol Chem; 2002 Oct; 277(41):39005-14. PubMed ID: 12145314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
    Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
    Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
    Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
    J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking the Cartoon mouse phenotype: Hemopexin domain-dependent regulation of MT1-MMP pericellular collagenolytic activity.
    Sakr M; Li XY; Sabeh F; Feinberg TY; Tesmer JJG; Tang Y; Weiss SJ
    J Biol Chem; 2018 May; 293(21):8113-8127. PubMed ID: 29643184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
    Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
    J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase.
    Lehti K; Lohi J; Juntunen MM; Pei D; Keski-Oja J
    J Biol Chem; 2002 Mar; 277(10):8440-8. PubMed ID: 11779859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
    Kolkenbrock H; Essers L; Ulbrich N; Will H
    Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.
    Wang Y; Johnson AR; Ye QZ; Dyer RD
    J Biol Chem; 1999 Nov; 274(46):33043-9. PubMed ID: 10551873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.
    Mori H; Tomari T; Koshikawa N; Kajita M; Itoh Y; Sato H; Tojo H; Yana I; Seiki M
    EMBO J; 2002 Aug; 21(15):3949-59. PubMed ID: 12145196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K; Lohi J; Valtanen H; Keski-Oja J
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration.
    Cao J; Kozarekar P; Pavlaki M; Chiarelli C; Bahou WF; Zucker S
    J Biol Chem; 2004 Apr; 279(14):14129-39. PubMed ID: 14729674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tetraspanin network modulates MT1-MMP cell surface trafficking.
    Schröder HM; Hoffmann SC; Hecker M; Korff T; Ludwig T
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1133-44. PubMed ID: 23500527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.
    Itoh Y; Kajita M; Kinoh H; Mori H; Okada A; Seiki M
    J Biol Chem; 1999 Nov; 274(48):34260-6. PubMed ID: 10567400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.
    Suenaga N; Mori H; Itoh Y; Seiki M
    Oncogene; 2005 Jan; 24(5):859-68. PubMed ID: 15558018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.
    English WR; Puente XS; Freije JM; Knauper V; Amour A; Merryweather A; Lopez-Otin C; Murphy G
    J Biol Chem; 2000 May; 275(19):14046-55. PubMed ID: 10799478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.